awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q28070296-671C46F2-07A2-42FB-A887-10BDAD253F16
Q28070296-671C46F2-07A2-42FB-A887-10BDAD253F16
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28070296-671C46F2-07A2-42FB-A887-10BDAD253F16
Development of proprotein convertase subtilisin/kexin type 9 inhibitors and the clinical potential of monoclonal antibodies in the management of lipid disorders
P2860
Q28070296-671C46F2-07A2-42FB-A887-10BDAD253F16
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28070296-671C46F2-07A2-42FB-A887-10BDAD253F16
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
31cca68dbde755556c204edb2726cdb20dc62e69
P2860
Efficacy and safety of evolocumab in reducing lipids and cardiovascular events.